At CIBER, basic and clinical researchers work together to make it easier for laboratory research to reach patients in an agile and safe way, avoiding duplication, achieving agile results and transferring the results of research to industry and society. The ISCIII, as a promoter and majority funding body, exercises the functions of monitoring and controlling all its activities.
It includes thirteen thematic areas present in almost all CAAC:
- Bioengineering, Biomaterials and Nanomedicine (CIBERBBN),
- Rare Diseases (CIBERER),
- Respiratory Diseases (CIBERES),
- Liver and Digestive Diseases (CIBEREHD),
- Epidemiology and Public Health (CIBERESP),
- Mental Health (CIBERSAM),
- Diabetes and Metabolic Diseases (CIBERDEM),
- Pathophysiology of Obesity and Nutrition (CIBEROBN),
- Fragility and Aging (CIBERFES),
- Cardiovascular Diseases (CIBERCV),
- Cancer (CIBERONC),
- Neurodegenerative Diseases (CIBERNED), and
- Infectious Diseases (CIBERINFEC).
